Residual electroretinograms in young leber congenital amaurosis patients with mutations of AIPL1

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 11, 2011, Pages 8166-8173

  Pennesi, Mark E ^a   Stover, Niamh B ^a   Stone, Edwin M ^b   Chiang, Pei Wen ^a   Weleber, Richard G ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; ARYL HYDROCARBON RECEPTOR INTERACTING PROTEIN LIKE 1 GENE; CASE REPORT; CHILD; ELECTRORETINOGRAPHY; EYE EXAMINATION; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; GENE; GENE MUTATION; GENETIC SCREENING; HUMAN; LEBER CONGENITAL AMAUROSIS; MALE; NIGHT VISION; NYSTAGMUS; PERIMETRY; PRESCHOOL CHILD; PRIORITY JOURNAL; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; COLOR VISION; DNA SEQUENCE; GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; RETINA; SIBLING; VISUAL FIELD;

AIPL1 PROTEIN, HUMAN; CARRIER PROTEIN; EYE PROTEIN;

ADOLESCENT; CARRIER PROTEINS; CHILD, PRESCHOOL; COLOR VISION; DNA MUTATIONAL ANALYSIS; ELECTRORETINOGRAPHY; EYE PROTEINS; FEMALE; HUMANS; LEBER CONGENITAL AMAUROSIS; MALE; MUTATION; NIGHT VISION; PHENOTYPE; POLYMERASE CHAIN REACTION; RETINA; SEQUENCE ANALYSIS, DNA; SIBLINGS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL FIELDS;

EID: 84855404911     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8298     Document Type: Article

References (35)

1. Foxman SG, Heckenlively JR, Bateman JB, Wirtschafter JD. Classification of congenital and early onset retinitis pigmentosa. Arch Ophthalmol. 1985;103:1502-1506.
2. Walia S, Fishman GA, Jacobson SG, et al. Visual acuity in patients with Leber's congenital amaurosis and early childhood-onset retinitis pigmentosa. Ophthalmology. 2010;117:1190-1198.
3. Weleber RG, Francis P, Trzupek K. Leber congenital amaurosis. GeneReviews [Internet]. Seattle: University of Washington, Seattle; 1993. July 27, 2004 [updated March 30, 2010].
4. den Hollander AI, Roepman R, Koenekoop RK, Cremers FP. Leber congenital amaurosis: genes, proteins and disease mechanisms. Prog Retin Eye Res. 2008;27:391-419.
5. Stone EM. Leber congenital amaurosis-a model for efficient genetic testing of heterogeneous disorders: LX Intravenous Edward Jackson Memorial Lecture. Am J Ophthalmol. 2007;144:791-811.
6. van der Spuy J, Kim JH, Yu YS, et al. The expression of the Leber congenital amaurosis protein AIPL1 coincides with rod and cone photoreceptor development. Invest Ophthalmol Vis Sci. 2003;44: 5396-5403.
7. Ramamurthy V, Roberts M, van den Akker F, Niemi G, Reh TA, Hurley JB. AIPL1, a protein implicated in Leber's congenital amaurosis, interacts with and aids in processing of farnesylated proteins. Proc Natl Acad Sci U S A. 2003;100:12630-12635.
8. Liu X, Bulgakov OV, Wen XH, et al. AIPL1, the protein that is defective in Leber congenital amaurosis, is essential for the biosynthesis of retinal rod cGMP phosphodiesterase. Proc Natl Acad Sci U S A. 2004;101:13903-13908.
9. Chapple JP, Grayson C, Hardcastle AJ, Saliba RS, van der Spuy J, Cheetham ME. Unfolding retinal dystrophies: a role for molecular chaperones? Trends Mol Med. 2001;7:414-421.
10. Kolandaivelu S, Huang J, Hurley JB, Ramamurthy V. AIPL1, a protein associated with childhood blindness, interacts with alphasubunit of rod phosphodiesterase (PDE6) and is essential for its proper assembly. J Biol Chem. 2009;284:30853-30861.
11. Hidalgo-de-Quintana J, Evans RJ, Cheetham ME, van der Spuy J. The Leber congenital amaurosis protein AIPL1 functions as part of a chaperone heterocomplex. Invest Ophthalmol Vis Sci. 2008;49: 2878-2887.
12. Akey DT, Zhu X, Dyer M, et al. The inherited blindness associated protein AIPL1 interacts with the cell cycle regulator protein NUB1. Hum Mol Genet. 2002;11:2723-2733.
13. van der Spuy J, Chapple JP, Clark BJ, Luthert PJ, Sethi CS, Cheetham ME. The Leber congenital amaurosis gene product AIPL1 is localized exclusively in rod photoreceptors of the adult human retina. Hum Mol Genet. 2002;11:823-831.
14. Kirschman LT, Kolandaivelu S, Frederick JM, et al. The Leber congenital amaurosis protein, AIPL1, is needed for the viability and functioning of cone photoreceptor cells. Hum Mol Genet. 2010; 19:1076-1087.
15. Sohocki MM, Perrault I, Leroy BP, et al. Prevalence of AIPL1 mutations in inherited retinal degenerative disease. Mol Genet Metab. 2000;70:142-150.
16. Jacobson SG, Cideciyan AV, Aleman TS, et al. Human retinal disease from AIPL1 gene mutations: foveal cone loss with minimal macular photoreceptors and rod function remaining. Invest Ophthalmol Vis Sci. 2011;52:70-79.
17. Sohocki MM, Bowne SJ, Sullivan LS, et al. Mutations in a new photoreceptor-pineal gene on 17p cause Leber congenital amaurosis. Nat Genet. 2000;24:79-83.
18. Dharmaraj S, Leroy BP, Sohocki MM, et al. The phenotype of Leber congenital amaurosis in patients with AIPL1 mutations. Arch Ophthalmol. 2004;122:1029-1037.
19. Galvin JA, Fishman GA, Stone EM, Koenekoop RK. Evaluation of genotype-phenotype associations in leber congenital amaurosis. Retina. 2005;25:919-929.
20. Sun X, Pawlyk B, Xu X, et al. Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutations. Gene Ther. 2010;17:117-131.
21. Tan MH, Smith AJ, Pawlyk B, et al. Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors. Hum Mol Genet. 2009;18:2099-2114.
22. Weleber RG, Gupta N, Trzupek KM, Wepner MS, Kurz DE, Milam AH. Electroretinographic and clinicopathologic correlations of retinal dysfunction in infantile neuronal ceroid lipofuscinosis (infantile Batten disease). Mol Genet Metab. 2004;83:128-137.
23. Weleber RG. The effect of age on human cone and rod Ganzfeld electroretinograms. Invest Ophthalmol Vis Sci. 1981;20:392-399.
24. Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2009;118:69-77.
25. Schiefer U, Pascual JP, Edmunds B, et al. Comparison of the new perimetric GATE strategy with conventional full-threshold and SITA standard strategies. Invest Ophthalmol Vis Sci. 2009;50:488-494.
26. Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med. 2008;358:2231-2239.
27. Cideciyan AV, Aleman TS, Boye SL, et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci U S A. 2008;105: 15112-15117.
28. Hauswirth WW, Aleman TS, Kaushal S, et al. Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther. 2008;19:979-990.
29. Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med. 2008;358:2240-2248.
30. Banin E, Bandah-Rozenfeld D, Obolensky A, et al. Molecular anthropology meets genetic medicine to treat blindness in the North African Jewish population: human gene therapy initiated in Israel. Hum Gene Ther. 2010;21:1749-1757.
31. van der Spuy J, Munro PM, Luthert PJ, et al. Predominant rod photoreceptor degeneration in Leber congenital amaurosis. Mol Vis. 2005;11:542-553.
32. Testa F, Surace EM, Rossi S, et al. Evaluation of Italian patients with Leber congenital amaurosis due to AIPL1 mutations highlights the potential applicability of gene therapy. Invest Ophthalmol Vis Sci. 2011;52:5618-5624.
33. Hanein S, Perrault I, Gerber S, et al. Leber congenital amaurosis: comprehensive survey of the genetic heterogeneity, refinement of the clinical definition, and genotype-phenotype correlations as a strategy for molecular diagnosis. Hum Mutat. 2004;23:306-317.
34. Lalwani K, Tompkins BD, Burnes K, Krahmer MR, Pennesi ME, Weleber RG. The 'dark' side of sedation: 12 years of office-based pediatric deep sedation for electroretinography in the dark. Paediatr Anaesth. 2011;21:65-71.
35. Pennesi ME, Stover NB, Johnsen S, et al. Results from a Twelve Year Experience with Propofol for Sedated ERGs: International Society for Clinical Electrophysiology of Vision. Padua, Italy: Springer; 2009.